Salvianolic acid B mitigates senescence and promotes osteogenesis of senescent bone marrow mesenchymal stem cells via the PI3K/AKT pathway
Shaozi Zhong, Dianxuan Wu, Qize Chen, Chun Zeng, Huabin Chen, Jie Huang · 2026
Read Salvianolic acid B mitigates senescence and promotes osteogenesis of senescent bone marrow mesenchymal stem cells via the PI3K/AKT pathway by Shaozi Zhong, Dianxuan Wu, Qize Chen, Chun Zeng, Huabin Chen, Jie Huang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13254721.txt.
Description
Shaozi Zhong and colleagues test a compound from the herb danshen on aging bone stem cells in a 2026 laboratory study. Salvianolic acid B is the most abundant active water-soluble ingredient of Salvia miltiorrhiza, a staple of Chinese medicine, and earlier evidence hinted it fights osteoporosis. What it does inside senescent bone marrow stem cells, whose fading bone-building capacity drives age-related bone loss, was unclear.
In cell culture, the compound both pushed the aged stem cells toward becoming bone-forming cells and rolled back markers of their senescence. A signaling pathway known as PI3K/AKT proved central: blocking it removed the benefits, identifying it as the route through which the compound acts. The authors say the work clarifies the cellular and molecular basis of the herb compound's reputation. It also lays theoretical groundwork for animal studies of whether the same rescue works in a living skeleton.
Catalog record
| CREATOR | Shaozi Zhong, Dianxuan Wu, Qize Chen, Chun Zeng, Huabin Chen, Jie Huang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |